AWP Inflation

This violation occurs when a company or individual inflates a drug's average wholesale price (AWP) above its actual market value (actual price) and then seeks Medicare or Medicaid payment, resulting in higher profit margins for pharmaceutical companies and higher costs for government agencies. These types of fraud can go undetected for long periods of time and can place a significant burden on taxpayers, resulting in undermining federal government funds.

Because Medicare and Medicaid are federal programs, charges of AWP inflation can carry severe penalties. Judges and juries in such cases will try to determine whether there was willful conduct, which can result in increased penalties and damages.  Often times, Medicare Fraud Charges, Medicaid Fraud Charges and/or private Insurance Fraud Charges can accompany allegations of AWP Inflation.

AWP & Pharmaceutical Crimes Defense

We at the Blanch Law Firm know that "AWP" violations can be subjective and open to interpretation. Free-market prices are often in flux and subject to dramatic rapid changes. If you or your company have been or may be charged with AWP inflation, you will need a dedicated team of attorneys with the experience necessary to construct an effective defense. Call 917-472-9883 or toll free at 1-866-690-9316 or E-mail now to schedule a confidential consultation with one of our experience Pharmaceutical Crimes Attorneys about your case at absolutely no cost to you.